Catalyst Wire Dossier Catalyst Wire Dossier

GSK3117391

GSK3117391 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK3117391, covering 2019-03-26 to 2019-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis [Phase 2]

See pricing